Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wanbin Li
Cancerous Inhibitor of Protein Phosphatase 2A Regulates Cisplatin Resistance in Ovarian Cancer
Oncology Letters
Cancer Research
Oncology
Related publications
ETS1 Mediates MEK1/2-Dependent Overexpression of Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) in Human Cancer Cells
PLoS ONE
Multidisciplinary
Protein Phosphatase 2A (PP2A) Inhibitor CIP2A Indicates Resistance to Radiotherapy in Rectal Cancer
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) Is an Independent Prognostic Marker in Wild-Type KRAS Metastatic Colorectal Cancer After Colorectal Liver Metastasectomy
BMC Cancer
Cancer Research
Oncology
Genetics
Mitigating Cisplatin Resistance in Ovarian Cancer.
FAM122A, a New Endogenous Inhibitor of Protein Phosphatase 2A
Oncotarget
Oncology
Cisplatin/Carboplatin Cross-Resistance in Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
Protein Phosphatase 2A Signaling in Human Prostate Cancer
MicroRNA‑218 Inhibits the Cell Proliferation and Migration in Clear Cell Renal Cell Carcinoma Through Targeting Cancerous Inhibitor of Protein Phosphatase 2A
Oncology Letters
Cancer Research
Oncology
Protein Phosphatase 2A (PP2A) Regulates Interleukin-4-Mediated STAT6 Signaling
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
